Back to Directory Judy Hopking Email judy.x.hopking@gsk.com Phone 0145-329-7423 Institution GlaxoSmithKline Address GlaxoSmithKline Stockley Park West 1-3 Ironbridge Road Uxbridge, Middlesex UB11 1BT United Kingdom Request an Update Affiliated Studies IMPAACT 2019: Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age DAIDS Number 38504 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
IMPAACT 2019: Phase I/II Study of the Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less than 12 Years of Age DAIDS Number 38504 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed